Article
β-Nicotinamide mononucleotide: a novel broad-spectrum CRISPR inhibitor
2025-11-26
Abstract excerpt
CRISPR–Cas systems have revolutionized genome editing with their precision and versatility, enabling transformative applications in various fields, especially in the treatment of genetic diseases. However, the clinical translation of this technology is hindered by challenges such as off-target effects and uncontrolled nuclease activity. At the same time, it has the possibility of causing biosecurity risks, undersc...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f5b69608-0ea3-580f-b15d-d64ffdf477cc
- DOI
- 10.1101/2025.11.22.685598
